PharmaBlock Sciences Nanjing Inc Class A (300725) — Capital Reinvestment Ratio
PharmaBlock Sciences Nanjing Inc Class A (300725) has a Capital Reinvestment Ratio of 0.05x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥83.36 Million) in capital expenditures (CN¥4.24 Million). See PharmaBlock Sciences Nanjing Inc Class A free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PharmaBlock Sciences Nanjing Inc Class A Capital Reinvestment Ratio (2013–2024)
This chart tracks PharmaBlock Sciences Nanjing Inc Class A's Capital Reinvestment Ratio across 12 annual periods.
Annual Capital Reinvestment Ratio for PharmaBlock Sciences Nanjing Inc Class A (2013–2024)
Year-by-year Capital Reinvestment Ratio for PharmaBlock Sciences Nanjing Inc Class A from 2013 to 2024. For live market cap and broader valuation context, see how much is PharmaBlock Sciences Nanjing Inc Class A worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.39x | CN¥302.82 Million | CN¥118.12 Million | ▼ -69.5% |
| 2023 | 1.28x | CN¥246.84 Million | CN¥315.77 Million | ▼ -43.5% |
| 2022 | 2.26x | CN¥246.61 Million | CN¥557.91 Million | ▲ +6.5% |
| 2021 | 2.12x | CN¥238.03 Million | CN¥505.76 Million | ▲ +667.3% |
| 2020 | 0.28x | CN¥271.51 Million | CN¥75.18 Million | ▼ -79.7% |
| 2019 | 1.37x | CN¥127.04 Million | CN¥173.52 Million | ▲ +351.6% |
| 2018 | 0.30x | CN¥160.16 Million | CN¥48.44 Million | ▼ -66.3% |
| 2017 | 0.90x | CN¥54.64 Million | CN¥49.06 Million | ▼ -46.6% |
| 2016 | 1.68x | CN¥22.76 Million | CN¥38.26 Million | ▲ +376.9% |
| 2015 | 0.35x | CN¥27.52 Million | CN¥9.70 Million | ▼ -55.7% |
| 2014 | 0.80x | CN¥11.91 Million | CN¥9.48 Million | ▲ +133.9% |
| 2013 | 0.34x | CN¥18.32 Million | CN¥6.23 Million | — |